Bolt Biotherapeutics, Inc. (BOLT) News
Track canonical SquawkNews coverage tagged to BOLT, Bolt Biotherapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Bolt Biotherapeutics Q2 EPS $(4.57) Misses $(2.88) Estimate, Sales $5.000K Miss $500.000K Estimate
Bolt Biotherapeutics (NASDAQ: BOLT ) reported quarterly losses of $(4.57) per share which missed the analyst consensus estimate of $(2.88) by 58.68 percent. This is a 2.47 percent decrease over losses of $(4.46) per shar
EARNINGS | Aug 11, 2026, 08:20 PM UTC
L
BOLT - Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
BOLT - Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
EARNINGS | Aug 11, 2026, 08:07 PM UTC